BE541853A - - Google Patents

Info

Publication number

BE541853A

BE541853A BE541853DA BE541853A BE 541853 A BE541853 A BE 541853A BE 541853D A BE541853D A BE 541853DA BE 541853 A BE541853 A BE 541853A

Authority

BE

Belgium

Prior art keywords

antibiotic

tetracycline

weight

fungicidin

composition

Prior art date

Links

• Espacenet
• Global Dossier
• Discuss

• 239000000203 mixture Substances 0.000 claims description 23
• 230000003115 biocidal effect Effects 0.000 claims description 17
• 229930101283 tetracycline Natural products 0.000 claims description 10
• 239000004098 Tetracycline Substances 0.000 claims description 9
• 229960002180 tetracycline Drugs 0.000 claims description 9
• 235000019364 tetracycline Nutrition 0.000 claims description 9
• 150000003522 tetracyclines Chemical class 0.000 claims description 9
• 239000013543 active substance Substances 0.000 claims description 8
• 238000000034 method Methods 0.000 claims description 5
• 239000000126 substance Substances 0.000 claims description 5
• 230000001225 therapeutic effect Effects 0.000 claims description 4
• 239000003937 drug carrier Substances 0.000 claims description 3
• 239000003981 vehicle Substances 0.000 claims description 2
• 238000004519 manufacturing process Methods 0.000 claims 2
• 239000003242 anti bacterial agent Substances 0.000 description 8
• 229940088710 antibiotic agent Drugs 0.000 description 7
• 150000001875 compounds Chemical class 0.000 description 5
• 208000015181 infectious disease Diseases 0.000 description 5
• 229940072172 tetracycline antibiotic Drugs 0.000 description 5
• 241000233866 Fungi Species 0.000 description 3
• 241001363490 Monilia Species 0.000 description 3
• 201000010099 disease Diseases 0.000 description 3
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
• 239000000463 material Substances 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• 239000004099 Chlortetracycline Substances 0.000 description 2
• 208000012868 Overgrowth Diseases 0.000 description 2
• 239000003795 chemical substances by application Substances 0.000 description 2
• CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 2
• 229960004475 chlortetracycline Drugs 0.000 description 2
• CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 2
• 235000019365 chlortetracycline Nutrition 0.000 description 2
• 239000003814 drug Substances 0.000 description 2
• 230000000694 effects Effects 0.000 description 2
• 239000007903 gelatin capsule Substances 0.000 description 2
• 244000005700 microbiome Species 0.000 description 2
• IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 2
• 229960004368 oxytetracycline hydrochloride Drugs 0.000 description 2
• 238000002360 preparation method Methods 0.000 description 2
• 150000003839 salts Chemical class 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 2
• MWKJTNBSKNUMFN-UHFFFAOYSA-N trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 description 2
• OGQYJDHTHFAPRN-UHFFFAOYSA-N 2-fluoro-6-(trifluoromethyl)benzonitrile Chemical compound FC1=CC=CC(C(F)(F)F)=C1C#N OGQYJDHTHFAPRN-UHFFFAOYSA-N 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• 208000035143 Bacterial infection Diseases 0.000 description 1
• 241000192125 Firmicutes Species 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• 239000004100 Oxytetracycline Substances 0.000 description 1
• 241000606701 Rickettsia Species 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• 241000700605 Viruses Species 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 239000004480 active ingredient Substances 0.000 description 1
• 230000000843 anti-fungal effect Effects 0.000 description 1
• 208000022362 bacterial infectious disease Diseases 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 229960003185 chlortetracycline hydrochloride Drugs 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 239000013058 crude material Substances 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 229940079593 drug Drugs 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 238000000855 fermentation Methods 0.000 description 1
• 230000004151 fermentation Effects 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 235000013355 food flavoring agent Nutrition 0.000 description 1
• 235000003599 food sweetener Nutrition 0.000 description 1
• 244000053095 fungal pathogen Species 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 229940060367 inert ingredients Drugs 0.000 description 1
• 231100000053 low toxicity Toxicity 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 229960000988 nystatin Drugs 0.000 description 1
• VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
• 229960000625 oxytetracycline Drugs 0.000 description 1
• 235000019366 oxytetracycline Nutrition 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 229910021653 sulphate ion Inorganic materials 0.000 description 1
• 239000003765 sweetening agent Substances 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1